Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.

Autor: Albalawi M; Department of Internal Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia., Zaidi SZA; Department of Adult Hematology/Blood & Marrow Transplant, King Fahad Medical City, Riyadh, Saudi Arabia., AlShehry N; Department of Adult Hematology/Blood & Marrow Transplant, King Fahad Medical City, Riyadh, Saudi Arabia., AlAskar A; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Zaidi ARZ; Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia., Abdallah RNM; Department of Pulmonary and Critical Care Medicine, King Fahad Medical City, Riyadh, Saudi Arabia., Salam A; Department of Epidemiology and Biostatistics, King Fahad Specialist Hospital, Dammam, Saudi Arabia., AlSagheir A; Department of Hematology and Oncology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia., AlMozain N; Department of Blood Bank, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Elgohary G; Oncology Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Batarfi K; Transfusion Medicine Services, Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alfaraedi A; King Saud University, Riyadh, Saudi Arabia., Khojah O; King Saud University, Riyadh, Saudi Arabia., Al-Ansari R; Department of Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia., Alfaraj M; Hematology Laboratory Section of Medical Laboratory Department, Qatif Central Hospital, Qatif, Saudi Arabia., Dayel A; Department of Hematopathology, King Fahad Specialist Hospital Dammam, Dammam, Saudi Arabia., Al Bahrani A; Department of Transfusion Medicine and Stem Cell Processing, King Fahad Specialist Hospital, Dammam, Saudi Arabia., Abdelhameed AN; Department of Internal Medicine, Imam Abdulrahman Bin Faisal University, Al-Khobar, Saudi Arabia., Alhumaidan H; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Al-Otaibi JM; Department of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Radwi G; Department of Hematology, University of Alberta, Edmonton, ON, Canada., Raizah A; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Shatry H; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alsaleh S; Department of Hematology and Oncology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia., AlZahrani H; Department of Hematology and Bone Marrow Transplantation Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Al-Hashmi H; Adult Hematology & Stem Cell Transplantation Department, Oncology Centre, King Fahad Specialist Hospital, Dammam, Saudi Arabia.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2020 Oct 02; Vol. 9 (10), pp. e23543. Date of Electronic Publication: 2020 Oct 02.